Search results
-
Dr Daniel Hodson
... to characterise how new therapeutic agents that are entering trials for lymphoma may exert some of their effect though changes in ...
-
Professor Tim Eisen
... AstraZeneca, where I am currently responsible for oncology trials from first in man to Phase II. ...
-
Dr Elena Provenzano
... My primary interest is the translational aspect of clinical trials particularly in the neoadjuvant setting. Current trials include ARTemis, PARTNER, PRIMETIME and Neo-RT clinical trials in ...
-
Dr Finian Leeper
... properties and a close relative obatoclax is in clinical trials for multiple cancers. (b) synthesis of thiamin diphosphate (TPP) ...
-
Dr Gaia Schiavon
... biomarkers and study designs in ‘window of opportunity’ trials - Identification of newer imaging criteria for response assessment to ... RECIST’s limitations - Pharmacodynamics in clinical trials, disease linkage data to guide indication selection and targeted patient ...
-
Dr George Follows
... post, and I am developing a translational science / clinical trials interest. I am the clinical lead for CLL and lymphoma in Cambridge, and chair the Haematology Clinical Trials team. I am a committee member of the Cambridge Clinical Cancer Trials ...
-
Professor Grant Stewart
... a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising ... Stewart has developed a range of interlinked clinical trials and translational research which are all underpinned by clinical ...
-
Dr Helen Morris
... and collaborated on a number of randomised controlled trials and other well-designed studies in the field of cancer and genetics in a ...
-
Dr Helen Hatcher
... lead investigator in several multicentre and international trials. ...
-
Dr Kelly Holmes
... setting up and co-ordinating the work for clinical research trials with the aim of developing novel imaging techniques in patients with ...
-
Dr Fengtong Ji
I am concentrating on promoting developmental mechanics and microrobotic engineering, aiming at developing interdisciplinary paradigms to investigate the mechanical and physical mechanisms governing the embryonic development and morphogenetic...
-
Dr Rafael Romero Garcia
Neurosurgical management of brain tumours has entered a new paradigm where resection is extended into the peri-tumoural margin to minimise ...
-
Dr Simon Pacey
As a Medical Oncologist trained in early drug development, my research interests are: Early phase clinical trials (phase I/II) and Urological malignancy (prostate cancers). My projects are centered around the transition of new drugs into humans and...
-
Dr Andrew Gee
... to cancer research is our work on ultrasound-guided radiotherapy and two- and three-dimensional elastography. ...
-
Dr Richard Benson
Interests based around improving radiotherapy and chemoradiotherapy in head and neck and urological cancers, develpoing technical radiotherapy and evaluating treatment related toxicity. ...
-
Dr Christopher Jones
... adenocarcinoma. I am also interested in the study of radiotherapy-related genomic evolution. ...
-
Professor Charlotte Coles
... III randomised trial (RCT) investigating intensity modulated radiotherapy (IMRT) and partial breast radiotherapy in patients at low risk of recurrence – in follow up: 2018 ...
-
Ms Ceilidh Welsh
... toxicity data, from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...
-
Professor David Neal
... Principal Investigator on large clinical trial of surgery, radiotherapy and monitoring in early prostate cancer (NHS R&D funded - £36M). ...
-
Dr David Noble
... anatomy of head and neck cancer patients undergoing curative radiotherapy. This model will permit calculation of delivered radiation dose ... in the move towards increasingly adaptive and individualised radiotherapy. ...
-
Dr Francesca M. Cozzi
... in concert with genetic analyses to inform surgical and radiotherapy planning. ...
-
Dr Gill Barnett
... the wide variation between patients in the severity of late radiotherapy toxicity. ...
-
Dr Henno Martin
... free DNA to discover markers of response and toxicity in radiotherapy for prostate and other cancers. ...
-
Dr Michael Boemo
... are pulsed into replicating DNA, they are incorporated into newly copied DNA by replication forks leaving a "footprint" of fork movement. ...
-
Dr John Lizhe Zhuang
... Barrett's oesophagus (BO). OAC is a lethal cancer often diagnosed at an advanced stage, and its incidence is increasing in Western ...
-
Dr Sarah Jefferies
... analysis and pseudo progression in patients treated for glioblastoma (T Booth, K Brindle; CRI) Collaborator in Gala 5 Study (CRUK grant ...
-
Miss Magda Gerigk
... working on developing microfluidic devices to mimic glioblastoma niches. ...
-
Dr Myriam Ouberai
I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...
-
Mr Richard Mair
... interested in understanding the heterogeneity present within glioblastoma and how this can be understood through the development of novel ...
-
Miss Ye Liu
My PhD project will be focused on glioblastoma, the most severe and deadly form of brain cancer; and the aim is ... space in order to measure migration/invasion abilities of glioblastoma cells. These cells are known to migrate along white matter tracts ... a physiologically relevant extracellular space within which glioblastoma cells can migrate and invade. Since our models are micron-scale, ...
